| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 01.10. | Roche Aligns with United Immunity on Master Clinical Supply Deal for mAb Checkpoint Inhibitor | ||
| 01.10. | 53Biologics Invests Over €2M in Lyophilization Expansion | ||
| 01.10. | Bespak Launches NasaDose Ultra Soft Unit Dose Spray | ||
| 01.10. | Biomay, Synthego Partner to Streamline cGMP CRISPR Manufacturing Services | ||
| 01.10. | SPI Pharma, Colorcon Forge Partner to Expand Oral Drug Delivery Solutions | ||
| 01.10. | Lonza Advances Aseptic Spray Drying Platform for High-Dose Biologics | ||
| 01.10. | BioDuro Names Greg Makara SVP of Lead Discovery Chemistry | ||
| 01.10. | Symbiosis Expands Commercial Team to Drive Growth in Europe, APAC Markets | ||
| 01.10. | Vir Biotechnology Appoints Aziz Sawaf as EVP and CFO | ||
| 01.10. | Samsung Bioepis, Teva Sign Global Biosimilars Deal | ||
| 01.10. | Fresenius Takes Full Ownership of mAbxience | ||
| 30.09. | T-CURX Appoints Florian Schmid Chief Financial Officer | ||
| 30.09. | Ensera Forms Alliance Network Uniting Device Platform & Fill-Finish Specialists | ||
| 30.09. | Piramal, NP2 Partner to Tackle Cyclophosphamide Shortages | ||
| 30.09. | Minaris Adds Dedicated Viral Vector Business Unit | ||
| 30.09. | ai3Bio Launches as Biotech Targeting Autoimmune Disease | ||
| 30.09. | ALK, Catalent Expand Long-Term Contract Manufacturing Collaboration | ||
| 30.09. | SK pharmteco to Invest Over $200M in U.S. Over Next 5 Years | ||
| 30.09. | OnDosis, Adare Partner on ADHD Drug | ||
| 30.09. | BioMed X, AbbVie Launch Anhedonia Research Team | ||
| 30.09. | Ontario Invests $1.75M in Piramal Pharma's Aurora Site | ||
| 29.09. | Neurocrine Biosciences Welcomes Back Eiry Roberts as Chief Medical Officer | ||
| 29.09. | ESTEVE CDMO Invests Additional $17.5M in Illinois Site | ||
| 29.09. | Forge, TECPR2 Research Foundation Strike AAV Gene Therapy Development, Manufacturing Partnership | ||
| 29.09. | Evotec Searches for New Chief Scientific Officer |